Clinical Trial Design Optimization and Problem Solving

Starting with the fall 2009 term, this course will be renumbered as BTC 6213.

Quantitative data analysis in the creation of dynamic drug-disease models, strategic market models, trial simulation models, and integrated financial models enable the analysis of key variables in development of clinical trials in real time. This integrated approach allows all decisions in the design to optimize value against both scientific and business criteria simultaneously and continuously. Students will learn to take a complete view of the development process at the outset -- across time, across the portfolio, and at all levels in the organization. This allows for greater insight into a drug's potential early in the development process and leads to a more focused development program for promising compounds, including an optimized clinical trial design. It also allows for earlier cessation of unpromising clinical trials, saving development time and funds.

There are no current sections scheduled for this course number.
Please note that courses have been assigned new numbers beginning with the fall term.
Please check the new course number for course availability.